Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Biomarket Trends: Molecular Diagnostics on the Move
Advances in Technology, Genetics, Genomics, and Personalized Medicine Drive Growth
- As technology advances, so does the molecular diagnostics market. New tests and new instruments to perform and automate analysis continue to expand the capabilities of companies in this segment. Furthermore, the identification and validation of novel genes and biomarkers makes it possible to develop and introduce even more tests. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.